Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples